Promissory Notes (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Dec. 15, 2025 |
Jul. 11, 2025 |
Feb. 21, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Jan. 23, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Short-Term Debt [Line Items] | ||||||||
| Effective interest rate | 28.40% | |||||||
| Derivative liability | $ 398 | $ 171 | ||||||
| Loss on the revaluation of the derivative liability | 227 | |||||||
| Convertible note payment terms | the Company is required to redeem the outstanding principal amount of the DNA Note for cash at a price equal to 110% of the then outstanding principal amount, plus accrued but unpaid interest and any other amounts then due under the DNA Note (the “Redemption Amount”), at the closing of such transaction. Notwithstanding the foregoing, the transactions contemplated by the Asset Purchase Agreement do not constitute a Change of Control Transaction under the DNA Note. In lieu of receiving the Redemption Amount, and subject to any required stockholder approval under the rules of the Company’s principal trading market, the holder may elect to convert the DNA Note, in whole or in part, upon a Change of Control Transaction at a price per share equal to the lower of (i) the closing price of common stock on the original issue date of the DNA Note and (ii) the closing price of common stock on the date of consummation of such Change of Control Transaction. | |||||||
| Principal amount | 15,000 | |||||||
| Payment of interest | 256 | |||||||
| Accrued interest | 199 | |||||||
| Accounts receivable | $ 57 | |||||||
| Measurement Input, Commodity Market Price [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Derivative liability, measurement input | 5.50 | |||||||
| Measurement Input, Share Price [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Derivative liability, measurement input | 4.03 | |||||||
| Measurement Input, Maturity [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Derivative liability, measurement input | 259 | |||||||
| Measurement Input, Price Volatility [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Derivative liability, measurement input | 165.6 | |||||||
| Measurement Input, Risk Free Interest Rate [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Derivative liability, measurement input | 3.7 | |||||||
| Asset Purchase Agreement [Member] | Streeterville Capital LLC [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Total payoff | $ 5,467 | |||||||
| Purchase Agreement | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Principal amount | $ 3,300 | |||||||
| July Purchase Agreement | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Principal amount | $ 2,755 | |||||||
| DNA Holdings Ventures Inc [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Convertble notes issued | $ 1,200 | |||||||
| Interest rate percentage | 10.00% | |||||||
| Interest rate percentage, default | 20.00% | |||||||
| Initial conversion price of convertible note | $ 5.50 | |||||||
| Effective interest rate | 10.00% | |||||||
| DNA Holdings Ventures Inc [Member] | Asset Purchase Agreement [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Covertible note terms, description | At any time after (i) the termination of the Asset Purchase Agreement or (ii) during the continuance of any event of default under the DNA Note, the conversion price will equal the “Alternate Conversion Price,” which is defined as 80% of the closing price of the Company’s common stock on the Company’s principal trading market on the date of conversion (subject to the same adjustment provisions described above). In addition, if at any time the Depository Trust Company imposes a “chill” on the Company’s shares, the holder may convert the DNA Note at the Alternate Conversion Price while such “chill” is in effect. | |||||||
| DNA Holdings Ventures Inc [Member] | Minimum [Member] | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Initial conversion price of convertible note | $ 1.10 | |||||||
| The February Note | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Interest rate percentage | 22.00% | |||||||
| Effective interest rate | 28.40% | |||||||
| Original issue discount | $ 270 | |||||||
| Payments for legal fees | 30 | |||||||
| Principal amount | 3,000 | |||||||
| Issuance costs | $ 210 | |||||||
| Interest rate | 9.00% | |||||||
| Outstanding percentage | 110.00% | |||||||
| Debt instrument redemption amount | $ 330 | |||||||
| Outstanding percentage | 1.00% | |||||||
| The February Note | Major Trigger Event | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Outstanding percentage | 15.00% | |||||||
| The February Note | Minor Trigger Event | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Outstanding percentage | 5.00% | |||||||
| July Note | ||||||||
| Short-Term Debt [Line Items] | ||||||||
| Interest rate percentage | 22.00% | |||||||
| Effective interest rate | 23.00% | |||||||
| Original issue discount | $ 225 | |||||||
| Payments for legal fees | 30 | |||||||
| Debt instrument redemption amount | $ 275 | |||||||
| Outstanding percentage | 1.00% | |||||||
| Purchase price | $ 2,500 | |||||||
| Issuance cost | $ 210 | |||||||
| Accrues interest rate | 9.00% | |||||||
| Debt instrument description | The Company may prepay all or any portion of the outstanding balance of the July Note. If the Company elects to prepay the July Note in part, it will be required to pay to the Lender an amount in cash equal to 110% of the portion of the outstanding balance the Company elects to prepay. In addition, any time the Company receives any money in connection with any fundraising or financing transaction (including, but not limited to, any warrant exercises, “at the market” financing, equity line of credit or debt financing), it must immediately make a mandatory prepayment to the Lender in an amount equal to the lesser of (a) 33% of the amount raised in such transaction, and (b) the total outstanding balance due under the July Note as of the closing date of such financing, payable within two trading days of receiving such amount. | |||||||